» Articles » PMID: 9030559

Phosphorylation by Protein Kinase C is Required for Acute Activation of Cystic Fibrosis Transmembrane Conductance Regulator by Protein Kinase A

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1997 Feb 21
PMID 9030559
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Protein kinase A (PKA) stimulates Cl secretion by activating the cystic fibrosis transmembrane conductance regulator (CFTR), a tightly regulated Cl- channel in the apical membrane of many secretory epithelia. The CFTR channel is also modulated by protein kinase C (PKC), but the regulatory mechanisms are poorly understood. Here we present evidence that PKA-mediated phosphorylation alone is not a sufficient stimulus to open the CFTR chloride channel in the presence of MgATP; constitutive PKC phosphorylation is essential for acute activation of CFTR by PKA. When patches were excised from transfected Chinese hamster ovary cells, CFTR responses to PKA became progressively smaller with time and eventually disappeared. This decline in PKA responsiveness did not occur in the presence of exogenous PKC and was reversed by the addition of PKC to channels that had become refractory to PKA. PKC enhanced PKA stimulation of open probability without increasing the number of functional channels. Short-term pretreatment of cells with the PKC inhibitor chelerythrine (1 microM) reduced the channel activity that could be elicited by forskolin in cell-attached patches. Moreover, in whole cell patches, acute stimulation of CFTR currents by chlorophenylthio-cAMP was abolished by two chemically unrelated PKC inhibitors, although an abrupt, partial activation was observed after a delay of >15 min. Modulation by PKC was most pronounced when basal PKC phosphorylation was reduced by briefly preincubating cells with chelerythrine. Constitutive PKC phosphorylation in unstimulated cells permits the maximum elevation of open probability by PKA to reach a level that is approximately 60% of that attained during in vitro exposure to both kinases. Differences in basal PKC activity may contribute to the variable cAMP responsiveness of CFTR channels in different cell types.

Citing Articles

Structural basis for the modulation of MRP2 activity by phosphorylation and drugs.

Mazza T, Roumeliotis T, Garitta E, Drew D, Rashid S, Indiveri C Nat Commun. 2024; 15(1):1983.

PMID: 38438394 PMC: 10912322. DOI: 10.1038/s41467-024-46392-8.


CRISPR/Cas9 bioluminescence-based assay for monitoring CFTR trafficking to the plasma membrane.

Ondra M, Lenart L, Centorame A, Dumut D, He A, Zaidi S Life Sci Alliance. 2023; 7(1).

PMID: 37918963 PMC: 10622324. DOI: 10.26508/lsa.202302045.


Pathogenic Relationships in Cystic Fibrosis and Renal Diseases: CFTR, SLC26A9 and Anoctamins.

Kunzelmann K, Ousingsawat J, Kraus A, Park J, Marquardt T, Schreiber R Int J Mol Sci. 2023; 24(17).

PMID: 37686084 PMC: 10487509. DOI: 10.3390/ijms241713278.


CyFi-MAP: an interactive pathway-based resource for cystic fibrosis.

Pereira C, Mazein A, Farinha C, Gray M, Kunzelmann K, Ostaszewski M Sci Rep. 2021; 11(1):22223.

PMID: 34782688 PMC: 8592983. DOI: 10.1038/s41598-021-01618-3.


Airway Epithelial Nucleotide Release Contributes to Mucociliary Clearance.

van Heusden C, Grubb B, Button B, Lazarowski E Life (Basel). 2021; 11(5).

PMID: 34064654 PMC: 8151306. DOI: 10.3390/life11050430.